• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Director Badavas Robert P was granted 3,873 shares, increasing direct ownership by 76% to 8,943 units (SEC Form 4)

    6/23/26 11:10:06 AM ET
    $HTGC
    Investment Managers
    Finance
    Get the next $HTGC alert in real time by email
    SEC FORM 4SEC Form 4
    FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number:3235-0287
    Estimated average burden
    hours per response:0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    BADAVAS ROBERT P

    (Last)(First)(Middle)
    C/O HERCULES CAPITAL, INC.
    1 NORTH B STREET, SUITE 2000

    (Street)
    SAN MATEO CALIFORNIA 94401

    (City)(State)(Zip)

    UNITED STATES

    (Country)
    2. Issuer Name and Ticker or Trading Symbol
    Hercules Capital, Inc. [ HTGC ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    XDirector10% Owner
    Officer (give title below)Other (specify below)
    2a. Foreign Trading Symbol
    3. Date of Earliest Transaction (Month/Day/Year)
    06/18/2026
    6. Individual or Joint/Group Filing (Check Applicable Line)
    XForm filed by One Reporting Person
    Form filed by More than One Reporting Person
    4. If Amendment, Date of Original Filed (Month/Day/Year)

    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    CodeVAmount(A) or (D)Price
    Common Stock122,073IBy Trust(1)
    Common Stock06/18/2026A3,873(2)A$15.498,943D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
    Explanation of Responses:
    1. Held by the Robert P. Badavas Trust of 2007
    2. Restricted Stock issued as an automatic grant upon re-election to the board of directors pursuant to the 2026 Non-Employee Director Plan and subject to forfeiture restrictions. One-third vests on the anniversary of the grant over three years.
    Remarks:
    /s /Kiersten Zaza Botelho, Attorney-in-Fact for Robert Badavas06/23/2026
    ** Signature of Reporting PersonDate
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    * Form 4: SEC 1474 (03-26)
    Get the next $HTGC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HTGC

    DatePrice TargetRatingAnalyst
    2/13/2026$17.50Overweight → Neutral
    Piper Sandler
    11/4/2025$19.50Neutral → Buy
    Compass Point
    12/12/2024$19.50 → $21.50Mkt Perform → Outperform
    Keefe Bruyette
    1/16/2024$17.00 → $17.50Buy → Neutral
    Compass Point
    11/21/2023$17.00Neutral
    UBS
    8/30/2023$17.50Neutral → Buy
    Compass Point
    8/4/2023$13.50 → $17.00Underperform → Mkt Perform
    Keefe Bruyette
    4/6/2023$16.00Neutral → Overweight
    Piper Sandler
    More analyst ratings

    $HTGC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Badavas Robert P was granted 3,873 shares, increasing direct ownership by 76% to 8,943 units (SEC Form 4)

    4 - Hercules Capital, Inc. (0001280784) (Issuer)

    6/23/26 11:22:36 AM ET
    $HTGC
    Investment Managers
    Finance

    Director Badavas Robert P was granted 3,873 shares, increasing direct ownership by 76% to 8,943 units (SEC Form 4)

    4 - Hercules Capital, Inc. (0001280784) (Issuer)

    6/23/26 11:10:06 AM ET
    $HTGC
    Investment Managers
    Finance

    Director Badavas Robert P was granted 3,873 shares, increasing direct ownership by 76% to 8,943 units (SEC Form 4)

    4 - Hercules Capital, Inc. (0001280784) (Issuer)

    6/23/26 11:07:58 AM ET
    $HTGC
    Investment Managers
    Finance

    $HTGC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Hercules Capital downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Hercules Capital from Overweight to Neutral and set a new price target of $17.50

    2/13/26 8:28:49 AM ET
    $HTGC
    Investment Managers
    Finance

    Hercules Capital upgraded by Compass Point with a new price target

    Compass Point upgraded Hercules Capital from Neutral to Buy and set a new price target of $19.50

    11/4/25 7:20:09 AM ET
    $HTGC
    Investment Managers
    Finance

    Hercules Capital upgraded by Keefe Bruyette with a new price target

    Keefe Bruyette upgraded Hercules Capital from Mkt Perform to Outperform and set a new price target of $21.50 from $19.50 previously

    12/12/24 8:09:58 AM ET
    $HTGC
    Investment Managers
    Finance

    $HTGC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Chief Operating Officer Follmann Christian bought $73,400 worth of shares (5,000 units at $14.68), increasing direct ownership by 3% to 150,135 units (SEC Form 4)

    4/A - Hercules Capital, Inc. (0001280784) (Issuer)

    3/5/26 5:19:12 PM ET
    $HTGC
    Investment Managers
    Finance

    Chief Operating Officer Follmann Christian decreased direct ownership by 3% to 150,135 units (SEC Form 4)

    4 - Hercules Capital, Inc. (0001280784) (Issuer)

    3/5/26 3:53:29 PM ET
    $HTGC
    Investment Managers
    Finance

    Director Randhawa Paramjeet K bought $45,079 worth of shares (3,050 units at $14.78), increasing direct ownership by 18% to 19,560 units (SEC Form 4)

    4 - Hercules Capital, Inc. (0001280784) (Issuer)

    3/5/26 2:54:35 PM ET
    $HTGC
    Investment Managers
    Finance

    $HTGC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Behavox Raises $175 Million from HPS Investment Partners, Part of BlackRock, to Accelerate Global Growth

    Investment follows a year of strong commercial momentum, with Behavox growing its customer base 86% to more than 100 major financial institutions across five continents Behavox, the AI-native controls platform for global banks, asset managers, hedge funds, and commodity firms, today announced a $175 million preferred equity investment from investment funds and accounts managed by HPS Investment Partners, a leading global credit investment firm and a part of BlackRock ("HPS"). The completed investment positions Behavox to accelerate global growth, expand its Unified Controls Platform, and pursue disciplined M&A. With this investment, HPS joins a roster of leading institutional investors

    6/17/26 10:00:00 AM ET
    $HTGC
    Investment Managers
    Finance

    Dyne Therapeutics Announces Expanded Debt Facility of Up To $400 Million with Hercules Capital, Inc.

    - Up to $125 million in additional borrowing capacity provides further strategic flexibility - - $50 million of additional capacity funded at amendment closing - WALTHAM, Mass., June 17, 2026 (GLOBE NEWSWIRE) --  Dyne Therapeutics, Inc. (NASDAQ:DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that it has entered into an amendment to its non-dilutive senior secured term loan facility with Hercules Capital, Inc. (NYSE:HTGC), a leader in customized debt financing for companies in the life sciences and technology-related markets. The transaction further strengthens the company's balan

    6/17/26 7:30:00 AM ET
    $DYN
    $HTGC
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Investment Managers
    Finance

    Beren Therapeutics Secures $300M Financing to Support the Potential Commercial Launch of Adrabetadex and Long-Term Care Initiatives for Infantile-Onset Niemann-Pick Disease, Type C

    -- $135 million equity financing with participation from leading specialist investors, corporate investors, and long-term growth partners, including Wellington Partners, JIC Venture Growth Investments (JIC VGI), Founders Fund, Narya Capital, Eisai Co., Ltd., and other select institutional investors -- Up to $165 million in flexible, non-dilutive capital, including $110 million senior-secured debt facility and $55 million of royalty financing with Hercules Capital, Inc. -- Financing will support investments in commercial readiness activities for adrabetadex ahead of its November 17, 2026, Prescription Drug User Fee Act (PDUFA) target action date. This will include the development of a long-t

    6/10/26 9:00:00 AM ET
    $HTGC
    Investment Managers
    Finance

    $HTGC
    SEC Filings

    View All

    Hercules Capital Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - Hercules Capital, Inc. (0001280784) (Filer)

    6/18/26 4:30:39 PM ET
    $HTGC
    Investment Managers
    Finance

    Hercules Capital Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    8-K - Hercules Capital, Inc. (0001280784) (Filer)

    5/5/26 4:30:24 PM ET
    $HTGC
    Investment Managers
    Finance

    SEC Form 10-Q filed by Hercules Capital Inc.

    10-Q - Hercules Capital, Inc. (0001280784) (Filer)

    5/5/26 4:17:04 PM ET
    $HTGC
    Investment Managers
    Finance

    $HTGC
    Leadership Updates

    Live Leadership Updates

    View All

    Snappt Acquires Trigo to Enhance Applicant Trust Platform for Multifamily Housing, Secures $50M Growth Financing

    Strategic growth financing accelerates expansion through acquisition and supports product innovation Snappt, the leading platform for applicant trust in multifamily housing, today announced it has acquired Trigo, a company known for its breakthrough technology in verifying rental payment history. Backed by a $50 million committed facility from Hercules Capital, Inc. (NYSE:HTGC), the acquisition expands Snappt's platform and strengthens its ability to help property managers make faster, more confident leasing decisions. Together, these milestones mark a major step toward building the industry's most complete and trusted solution embedded into the application and screening process. "This

    8/5/25 12:00:00 PM ET
    $HTGC
    Investment Managers
    Finance

    Revelation Partners Expands Team with Hire of Andrew Olson, Partner, Chief Financial Officer & Chief Operating Officer

    SAUSALITO, Calif., Nov. 29, 2023 /PRNewswire/ -- Revelation Partners, a healthcare investment firm with over $1.5 billion of capital under management, announced today the addition of Andrew Olson as Partner, Chief Financial Officer and Chief Operating Officer. Mr. Olson has an extensive background in the venture capital and funds management industry. His addition to the team will enhance the firm's technical expertise, support the differentiated investment model, and strengthen the firm's ongoing foundation. As the firm's new Chief Financial Officer and Chief Operating Officer

    11/29/23 1:01:00 PM ET
    $HTGC
    $TPVG
    Investment Managers
    Finance
    Other Consumer Services
    Consumer Discretionary

    Hercules Capital Announces the Appointment of Mr. Nikos Theodosopoulos to Its Board of Directors

    Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Nikos Theodosopoulos was appointed to serve as an independent member of its board of directors, effective September 21, 2023. Mr. Theodosopoulos is an experienced corporate executive and board director with more than 38 years in senior management roles in both the financial services and technology industries. Mr. Theodosopoulos will serve on the Company's Audit Committee. "Nikos' combined experienc

    9/25/23 6:00:00 AM ET
    $HCXY
    $HTGC
    Investment Managers
    Finance

    $HTGC
    Financials

    Live finance-specific insights

    View All

    Hercules Capital Announces Date of 2026 Annual Meeting of Stockholders

    Hercules Capital, Inc. (NYSE:HTGC) ("Hercules," "Hercules Capital," or the "Company"), will conduct its 2026 Annual Meeting of Stockholders by virtual meeting on Thursday, June 18, 2026 at 9:00 a.m. (Eastern Time). The proxy statement for the meeting was filed on April 23, 2026 and mailed to stockholders of record as of April 9, 2026. 2026 Annual Meeting of Stockholders June 18, 2026 at 9:00 a.m. Eastern Time Virtual Meeting via Internet: http://www.virtualshareholdermeeting.com/HTGC2026 Matters to be voted on include: 1) election of an independent director, 2) an advisory vote to approve the Company's named executive officer compensation, 3) an advisory vote on the frequency of the adv

    5/7/26 6:00:00 AM ET
    $HCXY
    $HTGC
    Investment Managers
    Finance

    Hercules Capital Reports First Quarter 2026 Financial Results

    Record Q1 2026 Total New Debt and Equity Commitments of $1.81 Billion, an Increase of 77.8% Year-over-Year Q1 2026 Total Fundings of $706.4 Million, an Increase of 31.0% Year-over-Year Record Q1 2026 Total Investment Income of $141.5 Million, an Increase of 18.4% Year-over-Year Q1 2026 Net Investment Income "NII" of $88.1 Million, an Increase of 13.8% Year-over-Year Q1 2026 NII of $0.48 per Share provides 120% Coverage of the Base Cash Distribution Closed Institutional Notes Offering of $300.0 Million of 5.350% Unsecured Notes due 2029 Conservative Balance Sheet Management with Net GAAP Leverage of 113.5% and Net Regulatory Leverage of 97.8%(1) Inclusive of the Adviser Funds A

    5/5/26 4:05:00 PM ET
    $HCXY
    $HTGC
    Investment Managers
    Finance

    Hercules Capital Announces Date for Release of First Quarter 2026 Financial Results and Conference Call

    Hercules Capital, Inc. (NYSE:HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its first quarter 2026 financial results conference call for Tuesday, May 5, 2026, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. All interested parties are invited to participate via telephone or the live webcast, which will be hosted on a webcast link located on the Investor Resources section of our

    4/21/26 6:00:00 AM ET
    $HCXY
    $HTGC
    Investment Managers
    Finance

    $HTGC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Hercules Capital Inc.

    SC 13G - Hercules Capital, Inc. (0001280784) (Subject)

    5/8/23 5:06:26 PM ET
    $HTGC
    Investment Managers
    Finance

    SEC Form SC 13G/A filed by Hercules Capital Inc. (Amendment)

    SC 13G/A - Hercules Capital, Inc. (0001280784) (Filed by)

    10/12/22 9:11:00 AM ET
    $HTGC
    Investment Managers
    Finance

    SEC Form SC 13G filed by Hercules Capital Inc.

    SC 13G - Hercules Capital, Inc. (0001280784) (Filed by)

    4/27/22 4:31:08 PM ET
    $HTGC
    Investment Managers
    Finance